Distinguished in Thyroid Cancer

Dr. Loren S. Michel

Hematology | Oncology
Atlantic Health
Memorial Sloan Kettering Cancer Center
136 Mountainview Boulevard, 
Basking Ridge, NJ 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth

Distinguished in Thyroid Cancer
Atlantic Health
Memorial Sloan Kettering Cancer Center
136 Mountainview Boulevard, 
Basking Ridge, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Loren Michel is a Hematologist and an Oncologist in Basking Ridge, New Jersey. Dr. Michel is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, Adenoid Cystic Carcinoma, and Epithelial-Myoepithelial Carcinoma. Dr. Michel is currently accepting new patients.

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Thyroid Cancer.

Graduate Institution
Case Western Reserve University
Residency
Mount Sinai Medical School
Specialties
Hematology
Oncology
Licenses
Internal Medicine in MO
Board Certifications
American Board Of Internal Medicine
Fellowships
Memorial Sloan-Kettering Cancer Center
Hospital Affiliations
Overlook Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Memorial Sloan Kettering Cancer Center
136 Mountainview Boulevard, Basking Ridge, NJ 07920
Call: 973-971-4340
Other Locations
Memorial Sloan Kettering Cancer Center
480 Red Hill Road, Middletown, NJ 07748
Call: 848-225-6113

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Enrollment Status: Recruiting
Publish Date: November 28, 2025
Intervention Type: Procedure
A Phase 1 Study of Concurrent Cabozantinib and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Cancer
A Phase 1 Study of Concurrent Cabozantinib and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug
Study Drugs: Cabozantinib, Cetuximab
Study Phase: Phase 1
A Phase 2 Study of MLN0128 (TAK-228) in Patients With Advanced Non-Small Cell Lung Cancers Harboring NFE2L2 and KEAP1 Mutations
A Phase 2 Study of MLN0128 (TAK-228) in Patients With Advanced Non-Small Cell Lung Cancers Harboring NFE2L2 and KEAP1 Mutations
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors
Enrollment Status: Terminated
Publish Date: July 08, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase II Study of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
A Phase II Study of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
Enrollment Status: Completed
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase I Trial of Pazopanib Suspension Plus Cetuximab in Patients With Incurable Head and Neck Squamous Cell Carcinoma
A Phase I Trial of Pazopanib Suspension Plus Cetuximab in Patients With Incurable Head and Neck Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: April 16, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

49 Total Publications

Organ Preservation for Nasal Cavity Cancers Using Definitive Radiotherapy for Avoiding Rhinectomy.
Organ Preservation for Nasal Cavity Cancers Using Definitive Radiotherapy for Avoiding Rhinectomy.
Journal: JAMA oncology
Published: December 11, 2025
View All 49 Publications
Similar Doctors
Elite in Thyroid Cancer
Dr. Eric J. Sherman
Oncology
Elite in Thyroid Cancer
Dr. Eric J. Sherman
Oncology

Memorial Solid Tumor Group

1275 York Ave, 
New York, NY 
 (0.1 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eric Sherman is an Oncologist in New York, New York. Dr. Sherman is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Carcinoma, Gastrostomy, and Liver Embolization.

Marcia S. Brose
Elite in Thyroid Cancer
Dr. Marcia S. Brose
Oncology
Elite in Thyroid Cancer
Dr. Marcia S. Brose
Oncology

Jefferson Torresdale Hospital

10800 Knights Road, 
Philadelphia, PA 
 (72.2 miles away)
215-890-3030
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marcia Brose is an Oncologist in Philadelphia, Pennsylvania. Dr. Brose is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Thyroid Cancer, Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Brose is currently accepting new patients.

Distinguished in Thyroid Cancer
Dr. Alexander D. Drilon
Oncology
Distinguished in Thyroid Cancer
Dr. Alexander D. Drilon
Oncology

Memorial Solid Tumor Group

530 E 74th St, 
New York, NY 
 (0.3 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alexander Drilon is an Oncologist in New York, New York. Dr. Drilon is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer.

VIEW MORE THYROID CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Michel's expertise for a condition
ConditionClose
  • Elite
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
    Dr. Michel is
    Elite
    . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
    See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
  • Distinguished
  • Adenoid Cystic Carcinoma
    Dr. Michel is
    Distinguished
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • Epithelial-Myoepithelial Carcinoma
    Dr. Michel is
    Distinguished
    . Learn about Epithelial-Myoepithelial Carcinoma.
    See more Epithelial-Myoepithelial Carcinoma experts
  • Glioma
    Dr. Michel is
    Distinguished
    . Learn about Glioma.
    See more Glioma experts
  • Polymorphous Low Grade Adenocarcinoma
    Dr. Michel is
    Distinguished
    . Learn about Polymorphous Low Grade Adenocarcinoma.
    See more Polymorphous Low Grade Adenocarcinoma experts
  • Thyroid Cancer
    Dr. Michel is
    Distinguished
    . Learn about Thyroid Cancer.
    See more Thyroid Cancer experts
  • Advanced
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Michel is
    Advanced
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • Anaplastic Thyroid Cancer
    Dr. Michel is
    Advanced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Follicular Thyroid Cancer
    Dr. Michel is
    Advanced
    . Learn about Follicular Thyroid Cancer.
    See more Follicular Thyroid Cancer experts
  • Laryngeal Cancer
    Dr. Michel is
    Advanced
    . Learn about Laryngeal Cancer.
    See more Laryngeal Cancer experts
  • Medullary Thyroid Carcinoma
    Dr. Michel is
    Advanced
    . Learn about Medullary Thyroid Carcinoma.
    See more Medullary Thyroid Carcinoma experts
  • Nasopharyngeal Carcinoma
    Dr. Michel is
    Advanced
    . Learn about Nasopharyngeal Carcinoma.
    See more Nasopharyngeal Carcinoma experts
View All 12 Advanced Conditions
  • Experienced
  • Bone Tumor
    Dr. Michel is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Breast Cancer
    Dr. Michel is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Ear Cancer
    Dr. Michel is
    Experienced
    . Learn about Ear Cancer.
    See more Ear Cancer experts
  • Familial Pancreatic Cancer
    Dr. Michel is
    Experienced
    . Learn about Familial Pancreatic Cancer.
    See more Familial Pancreatic Cancer experts
  • Glomus Jugulare Tumor
    Dr. Michel is
    Experienced
    . Learn about Glomus Jugulare Tumor.
    See more Glomus Jugulare Tumor experts
  • Glomus Tympanum Tumor
    Dr. Michel is
    Experienced
    . Learn about Glomus Tympanum Tumor.
    See more Glomus Tympanum Tumor experts
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.